Vijaya Diagnostic
Ticker > Company >

Vijaya Diagnostic share price

Vijaya Diagnostic Centre Ltd.

NSE: VIJAYA BSE: 543350 SECTOR: Hospital & Healthcare Services  2.03 L   218   49

1108.80
+20.35 (1.87%)
BSE: 05 Sep 04:01 PM

Price Summary

Today's High

₹ 1114.9

Today's Low

₹ 1085.9

52 Week High

₹ 1276.75

52 Week Low

₹ 800

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 11390.14 Cr.

Enterprise Value

₹ 11348.94 Cr.

No. of Shares

10.27 Cr.

P/E

78.81

P/B

13.89

Face Value

₹ 1

Div. Yield

0.18 %

Book Value (TTM)

₹  79.81

CASH

₹ 41.2 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

52.63 %

EPS (TTM)

₹  14.07

Sales Growth

19.45%

ROE

18.84 %

ROCE

28.71%

Profit Growth

17.81 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year19.45%
3 Year11.63%
5 Year13.8%

Profit Growth

1 Year17.81%
3 Year7.69%
5 Year17.13%

ROE%

1 Year18.84%
3 Year18.16%
5 Year21.32%

ROCE %

1 Year28.71%
3 Year28.05%
5 Year32.04%

Debt/Equity

0

Price to Cash Flow

55.13

Interest Cover Ratio

8.264

CFO/PAT (5 Yr. Avg.)

1.57944920168859

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 52.63 0.00
Mar 2025 53.05 0.00
Dec 2024 53.91 0.00
Sep 2024 53.91 0.00
Jun 2024 53.93 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 28.05% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 8.264.
  • The Company has been maintaining an effective average operating margins of 41.7328774822796% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -131.6493 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.57944920168859.
  • The company has a high promoter holding of 52.63%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 21.4585678007473.

 Limitations

  • The company has shown a poor profit growth of 7.69019070862926% for the Past 3 years.
  • The company has shown a poor revenue growth of 11.6264243202549% for the Past 3 years.
  • The company is trading at a high PE of 78.81.
  • The company is trading at a high EV/EBITDA of 39.2617.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 142.42 168.61 156.26 159.85 174.85
Total Expenditure 86.7 98.45 93.78 95.7 105.47
Operating Profit 55.72 70.16 62.48 64.15 69.38
Other Income 3.83 4.8 4.99 5.68 7.42
Interest 6.05 6.07 6.26 6.58 6.9
Depreciation 15.19 15.37 16.86 17.11 18.33
Exceptional Items 0 0 0 -1.03 0
Profit Before Tax 38.31 53.53 44.35 45.11 51.57
Tax 9.45 14.03 10.82 12 13.18
Profit After Tax 28.86 39.5 33.53 33.12 38.39
Adjusted EPS (Rs) 2.81 3.85 3.27 3.23 3.74

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 367.32 450.88 449.58 525.02 627.14
Total Expenditure 204.02 251.02 270.61 316.01 374.63
Operating Profit 163.3 199.86 178.97 209.01 252.51
Other Income 10.83 12.92 14.57 24.63 19.3
Interest 14.81 16.26 20.88 23.71 24.96
Depreciation 49.73 52.14 61.39 55.41 64.52
Exceptional Items 0 0 0 -2.05 -1.03
Profit Before Tax 109.59 144.38 111.27 152.47 181.3
Tax 26.76 36.28 28.04 37.87 46.29
Net Profit 82.82 108.1 83.23 114.6 135.01
Adjusted EPS (Rs.) 8.12 10.6 8.15 11.2 13.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.53 10.2 10.21 10.23 10.26
Total Reserves 356.02 459.78 534.88 643.09 773.26
Borrowings 0 0 0 0 0
Other N/C liabilities 127.99 169.23 232.64 240.84 287.63
Current liabilities 38.81 63.35 64.64 66.01 152.77
Total Liabilities 527.35 702.56 842.37 960.17 1223.93
Assets
Net Block 260.57 352.61 506.1 571.45 660.86
Capital WIP 8.18 34.1 27.11 8.2 67.18
Intangible WIP 1.24 0.07 0.63 0.42 0
Investments 4.87 4.87 4.87 144.5 144.5
Loans & Advances 9.73 32.79 19.99 25.9 39.01
Other N/C Assets 8.66 13.79 13.87 13.54 17.02
Current Assets 234.1 264.33 269.8 196.15 295.36
Total Assets 527.35 702.56 842.37 960.17 1223.93
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 109.59 144.38 111.27 152.47 181.3
Adjustment 52.55 55.97 67.58 57.16 70.21
Changes in Assets & Liabilities -3.13 -5.75 9.86 -1.4 -7.71
Tax Paid -31.17 -39.17 -26.07 -33.46 -37.19
Operating Cash Flow 127.84 155.42 162.64 174.77 206.61
Investing Cash Flow -128.82 -126.63 -108.48 -139.15 -165.37
Financing Cash Flow -48.19 -24.72 -41.26 -43.35 -46.84
Net Cash Flow -49.17 4.08 12.9 -7.73 -5.6

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 53.93 53.91 53.91 53.05 52.63
birudavolu gautam 0.01 0.01 0.01 0.01 0.01
birudavolu vishnu priya 0.03 0.03 0.03 0.03 0.03
geetha reddy sura 3.96 3.95 3.95 3.95 3.95
p madhulika 0.01 0.01 0.01 0.01 0.01
sunil chandra kondapally 8.38 8.38 8.38 7.98 7.57
suprita sura reddy - - - - 8.74
surendranath reddy sura 32.58 32.57 32.57 32.31 32.30
venkata sanjay kumar puli... 0.01 0.01 0.01 0.01 0.01
suprita s reddy 8.94 8.94 8.94 8.74 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 46.07 46.09 46.09 46.95 47.37
aberdeen new india invest... 1.69 1.69 1.43 1.44 1.44
abrdn asia focus plc - 1.76 1.67 1.25 1.25
axis mutual fund trustee ... 2.97 - - 4.01 3.85
hsbc small cap fund - - - 1.46 1.46
kotak small cap fund 3.19 4.99 5.22 5.74 5.58
motilal oswal nifty small... - - 1.17 1.07 1.12
nippon life india trustee... 6.21 - - - 5.82
the india fund inc 1.87 1.87 1.70 1.55 1.45
the prudential assurance ... - - - - 1.04
wasatch emerging india fu... 3.21 3.16 2.32 2.24 2.24
nippon life india trustee... - - - 5.10 -
the prudential assurance ... - - - 1.06 -
axis mutual fund trustee ... - 3.05 3.48 - -
mirae asset great consume... - 2.49 2.34 - -
nippon life india trustee... - 6.09 5.63 - -
aberdeen standard asia fo... 1.68 - - - -
al mehwar commercial inve... 2.93 - - - -
mirae asset midcap fund 3.24 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY25
Concall Q4FY24
Concall Q4FY23
Concall Q3FY25
Concall Q3FY23
Concall Q3FY22
Concall Q2FY24
Concall Q2FY22
Concall Q1FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22

Company News

Vijaya Diagnostic Centre informs about newspaper publication 29 Jul, 1:05 PM Vijaya Diagnostic - Quaterly Results 28 Jul, 1:29 PM Vijaya Diagnostic - Quaterly Results 28 Jul, 1:29 PM Vijaya Diagnostic - Quaterly Results 28 Jul, 1:29 PM Vijaya Diagnostic Centre informs about board meeting 18 Jul, 3:31 PM Vijaya Diagnostic Centre submits analyst meet intimation 18 Jul, 3:10 PM Vijaya Diagnostic Centre informs about analyst meet 13 May, 5:30 PM Vijaya Diagnostic - Quaterly Results 12 May, 2:26 PM Vijaya Diagnostic - Quaterly Results 12 May, 2:26 PM Vijaya Diagnostic - Quaterly Results 12 May, 2:26 PM Vijaya Diagnostic Centre informs about scrutinizers report 28 Apr, 4:11 PM Vijaya Diagnostic Centre informs about investor meet 20 Feb, 11:50 AM Vijaya Diagnostic Centre informs about analyst meet 18 Feb, 4:56 PM Vijaya Diagnostic - Quaterly Results 12 Feb, 1:49 PM Vijaya Diagnostic - Quaterly Results 12 Feb, 1:49 PM Vijaya Diagnostic - Quaterly Results 12 Feb, 1:49 PM Vijaya Diagnostic Centre informs about analyst meet 10 Feb, 3:20 PM Vijaya Diagnostic Centre informs about analyst meet 18 Nov, 1:26 PM Vijaya Diagnostic - Quaterly Results 7 Nov, 12:00 PM Vijaya Diagnostic - Quaterly Results 7 Nov, 12:00 PM Vijaya Diagnostic - Quaterly Results 7 Nov, 12:00 PM Vijaya Diagnostic Centre informs about newspaper advertisements 14 Aug, 12:36 PM Vijaya Diagnostic - Quaterly Results 5 Aug, 2:10 PM Vijaya Diagnostic - Quaterly Results 5 Aug, 2:10 PM Vijaya Diagnostic - Quaterly Results 5 Aug, 2:10 PM Vijaya Diagnostic Centre informs about board meeting 27 Jul, 2:57 PM Vijaya Diagnostic Centre informs about certificate 11 Jul, 12:29 PM Vijaya Diagnostic - Quaterly Results 8 May, 4:11 PM Vijaya Diagnostic - Quaterly Results 8 May, 4:11 PM Vijaya Diagnostic - Quaterly Results 8 May, 4:11 PM Vijaya Diagnostic Centre informs about compliance certificate 6 Apr, 11:55 AM Vijaya Diagnostic Centre informs about analyst meet 17 Feb, 9:57 AM Vijaya Diagnostic - Quaterly Results 5 Feb, 2:46 PM Vijaya Diagnostic - Quaterly Results 5 Feb, 2:46 PM Vijaya Diagnostic - Quaterly Results 5 Feb, 2:46 PM Vijaya Diagnostic Centre informs about disclosure 30 Jan, 10:53 AM Vijaya Diagnostic Centre informs about press release 8 Nov, 12:35 PM Vijaya Diagnostic - Quaterly Results 7 Nov, 1:52 PM Vijaya Diagnostic - Quaterly Results 7 Nov, 1:52 PM Vijaya Diagnostic Centre informs about disclosure 2 Nov, 10:46 AM Vijaya Diagnostic Centre submits analyst meet intimation 30 Oct, 3:59 PM Vijaya Diagnostic Centre informs about ODR Portal 19 Oct, 5:11 PM Vijaya Diagnostic Centre informs about board meeting 19 Oct, 5:08 PM Vijaya Diagnostic Centre informs about analyst meet 21 Sep, 4:23 PM Vijaya Diagnostic - Quaterly Results 9 Aug, 2:22 PM Vijaya Diagnostic - Quaterly Results 9 Aug, 2:22 PM Vijaya Diagnostic - Quaterly Results 9 Aug, 2:22 PM Vijaya Diagnostic Centre informs about allotment of ESOP 22 Jun, 1:22 PM Vijaya Diagnostic Centre informs about newspaper publication 31 May, 4:52 PM Vijaya Diagnostic - Quaterly Results 29 May, 6:08 PM

Vijaya Diagnostic Stock Price Analysis and Quick Research Report. Is Vijaya Diagnostic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vijaya Diagnostic. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vijaya Diagnostic has a PE ratio of 78.69169373352 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vijaya Diagnostic has ROA of 12.3632% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vijaya Diagnostic has a Current ratio of 1.9333.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vijaya Diagnostic has a ROE of 18.8361%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Vijaya Diagnostic has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Vijaya Diagnostic has reported revenue growth of 19.4496% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Vijaya Diagnostic for the current financial year is 40.2637699069183%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vijaya Diagnostic is Rs 2 and the yield is 0.1804%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vijaya Diagnostic is Rs 14.0701. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vijaya Diagnostic in Ticker for free. Also, one can get the intrinsic value of Vijaya Diagnostic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Vijaya Diagnostic FAQs

Q1. What is Vijaya Diagnostic share price today?
Ans: The current share price of Vijaya Diagnostic is Rs 1107.2.

Q2. What is the market capitalisation of Vijaya Diagnostic?
Ans: Vijaya Diagnostic has a market capitalisation of Rs 11373.70491392 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Vijaya Diagnostic?
Ans: The PE ratio of Vijaya Diagnostic is 78.69169373352 and the P/B ratio of Vijaya Diagnostic is 13.8730873132421, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Vijaya Diagnostic share?
Ans: The 52-week high share price of Vijaya Diagnostic is Rs 1275, and the 52-week low share price of Vijaya Diagnostic is Rs 740.

Q5. Does Vijaya Diagnostic pay dividends?
Ans: Currently, Vijaya Diagnostic pays dividends. Dividend yield of Vijaya Diagnostic is around 0.1804%.

Q6. What are the face value and book value of Vijaya Diagnostic shares?
Ans: The face value of Vijaya Diagnostic shares is Rs 1, while the book value per share of Vijaya Diagnostic is around Rs 79.8092. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Vijaya Diagnostic?
Ans: Vijaya Diagnostic has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Vijaya Diagnostic?
Ans: The ROE of Vijaya Diagnostic is 18.8361% and ROCE of Vijaya Diagnostic is 28.7102%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Vijaya Diagnostic a good buy for the long term?
Ans: The Vijaya Diagnostic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Vijaya Diagnostic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Vijaya Diagnostic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Vijaya Diagnostic’s financials?
Ans: You can review Vijaya Diagnostic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Vijaya Diagnostic

Vijaya Diagnostic Centre Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Vijaya Diagnostic Centre Ltd. is a leading diagnostic chain in Southern India providing a wide range of medical diagnostic services such as imaging, pathology, and cardiology. It was founded in 1981 by Dr. S. Surendranath Reddy and has grown rapidly over the years, setting up state-of-the-art medical diagnostic facilities across Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.

With a strong focus on high quality diagnostic services, Vijaya Diagnostic Centre Ltd. has become a trusted name in the medical community. The company offers a range of diagnostic services, including CT scans, MRI, X-rays, mammograms, and ultrasounds, among others.

Vijaya Diagnostic Centre Ltd. - Share Price

The share price of Vijaya Diagnostic Centre Ltd. has seen an upward trend since the company's IPO in September 2021. The stock opened at Rs. 542 and has since witnessed a steady increase, reaching a high of Rs. 867 in November 2021.

Investors looking for a long-term investment opportunity in the healthcare industry may find Vijaya Diagnostic Centre Ltd. to be an attractive option.

At our website, we provide pre-built screening tools that enable investors to filter stocks based on specific criteria such as market capitalization, sector, and financial ratios, among others. This tool can help investors make informed investment decisions based on their specific investment objectives.

Vijaya Diagnostic Centre Ltd. - Balance Sheet

The balance sheet is an important financial statement used to analyze the financial health of a company. At our website, Vijaya Diagnostic Centre Ltd.'s annual report and financial statements are available for download.

Our premium features, such as the DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can help investors to analyze the financial statements and calculate fair value for the company.

Vijaya Diagnostic Centre Ltd. - Annual Report

The annual report provides a comprehensive overview of the company's financial performance and operations over the past year. Vijaya Diagnostic Centre Ltd.'s annual reports are available for download on our website.

By analyzing the annual report, investors can gain insights into the company's financial health, market position, and future growth prospects.

Vijaya Diagnostic Centre Ltd. - Dividend

Vijaya Diagnostic Centre Ltd. has not declared any dividend since its IPO, as the company is focused on reinvesting its profits for future growth.

Vijaya Diagnostic Centre Ltd. - Quarterly Result

The quarterly results provide a snapshot of the company's financial performance over the preceding three-month period. Vijaya Diagnostic Centre Ltd.'s quarterly results are available for download on our website.

Using our premium features such as the DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can help investors analyze the financial performance and forecast future earnings of the company.

Vijaya Diagnostic Centre Ltd. - Stock Price

Vijaya Diagnostic Centre Ltd.'s stock price is subject to market fluctuations and various other factors. Investors should conduct thorough research before investing in the company.

At our website, investors can access real-time stock prices, historical data, and interactive charts to monitor the performance of the stock.

Vijaya Diagnostic Centre Ltd. - Price Chart

The historical price chart of the stock is a useful tool for analyzing the stock's performance over time. Our website provides interactive price charts that enable investors to visualize the company's stock price performance.

Vijaya Diagnostic Centre Ltd. - News

Staying informed about the latest news and developments related to a company is crucial for making informed investment decisions. Our website provides the latest news and updates related to Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. - Concall Transcripts

The conference call transcript is a valuable resource for investors, providing insights into the company's management, business strategy, and financial performance. At our website, Vijaya Diagnostic Centre Ltd.'s concall transcripts are available for download.

Vijaya Diagnostic Centre Ltd. - Investor Presentations

Investor presentations are another source of valuable information for investors, providing an overview of the company's operations, financial performance, and future growth prospects. Vijaya Diagnostic Centre Ltd.'s investor presentations are available for download on our website.

Vijaya Diagnostic Centre Ltd. - Promoters

Vijaya Diagnostic Centre Ltd. has a strong promoter group composed of Dr. S. Surendranath Reddy, Dr. K. S. Ratnakar, and Ms. Sunitha Reddy. This group has been instrumental in driving the company's growth and success over the years.

Vijaya Diagnostic Centre Ltd. - Shareholders

Vijaya Diagnostic Centre Ltd. has a diversified shareholder base, with retail investors, institutional investors, and promoters holding significant stakes in the company. At our website, investors can access information about the company's shareholding pattern and major shareholders.

In conclusion, Vijaya Diagnostic Centre Ltd. is a rapidly growing company in the healthcare industry, with a strong focus on providing high-quality diagnostic services. Investors looking for a long-term investment opportunity in the healthcare industry may find Vijaya Diagnostic Centre Ltd. to be an attractive option. Our website provides a range of tools and resources to help investors make informed investment decisions and stay informed about the latest developments related to the company. 

Vijaya Diagnostic Centre Balance Sheet Overview

Analyzing the financial stability of Vijaya Diagnostic Centre, the balance sheet figures indicate a strengthening position year over year. As of March 2024, the company has shown a consistent increase in total liabilities and assets, both valuing Rs 960.17 Cr., suggesting a balanced financial structure.

Vijaya Diagnostic Centre's Growing Reserves

Vijaya Diagnostic Centre has shown a commendable rise in total reserves from Rs 272.97 Cr. in March 2020 to Rs 643.09 Cr. by March 2024. This substantial growth mirrors the company's retained earnings and overall financial fortitude.

Vijaya Diagnostic Centre's Debt Position

The balance sheet data reflects a significant drop in borrowings to Rs 0 Cr. from March 2021 onwards, which underscores Vijaya Diagnostic Centre's move towards a debt-free status, positively impacting its creditworthiness.

Vijaya Diagnostic Centre's Asset Base Expansion

The net block, an indicator of the company's fixed assets, has impressively grown to Rs 571.45 Cr. by March 2024, while investments have surged to Rs 144.50 Cr., signaling strategic asset accumulation and diversification.

This analysis is based on the Standalone Balance Sheet of Vijaya Diagnostic Centre.

Vijaya Diagnostic Centre is a notable player in the healthcare sector, and its financial trend may offer insights for investors tracking healthcare stocks within the NSE/BSE indices.

Read More
X